Skip to main content
. 2015 Nov 30;5:17565. doi: 10.1038/srep17565

Figure 7. Supplementation with either CA or UDCA ameliorated hyperglycemia of InsrP1195L/+/HFD mice.

Figure 7

(a,b) Changes in body weight (a) and blood glucose levels (b). (c) mRNA expressions of G6pc in liver in fasted and refed conditions (n = 5–8 per each group). *,†only the statistical difference between supplementation with or without CA in InsrP1195L/+/HFD mice (*) and in WT/HFD () is depicted by symbols in (a,b). Data are mean ± SEM. Significance between treatment at individual time points by two-tailed Student’s t-test (a,b). Two-way ANOVA plus Bonferroni post-hoc analysis (c). *,†P < 0.05, **,††P < 0.01, ***,†††P < 0.001.